Human umbilical cord mesenchymal stem cells: A new era for stem cell therapy

Cell Transplantation

Volumn 24, Issue 3, 2015, Pages 339-347

  Ding, Dah Ching ^a   Chang, Yu Hsun ^a   Shyu, Woei Cherng ^b   Lin, Shinn Zong ^b,c  

^a TZU CHI UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY BEIGANG HOSPITAL   (Taiwan)

Author keywords

Clinical application; Stem cells; Umbilical cord; Wharton s jelly

Indexed keywords

BIOLOGICAL MARKER; CELL MARKER;

ADIPOCYTE; ANTINEOPLASTIC ACTIVITY; BLOOD STORAGE; CARTILAGE; CELL DIFFERENTIATION; CORD BLOOD STEM CELL TRANSPLANTATION; ECTODERM; EMBRYONIC STEM CELL; ENDODERM; FEEDER CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; LIVER; MESENCHYMAL STEM CELL; MESODERM; NEOPLASM; OSTEOCYTE; PANCREAS ISLET CELL; PRIORITY JOURNAL; REVIEW; SAFETY; STEM CELL; THERAPY EFFECT; UMBILICAL CORD; UMBILICAL CORD STEM CELL; ANIMAL; BIOLOGICAL THERAPY; CYTOLOGY; DISEASE MODEL; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; NEOPLASMS;

ANIMALS; BIOMARKERS; CELL DIFFERENTIATION; CELL- AND TISSUE-BASED THERAPY; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOMODULATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; NEOPLASMS; UMBILICAL CORD;

EID: 84927128220     PISSN: 09636897     EISSN: 15553892     Source Type: Journal    
DOI: 10.3727/096368915X686841     Document Type: Review

References (77)

1. Ayuzawa, R.; Doi, C.; Rachakatla, R. S.; Pyle, M. M.; Maurya, D. K.; Troyer, D.; Tamura, M. Naive human umbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in vitro and in vivo. Cancer Lett. 280(1):31–37; 2009
2. Campard, D.; Lysy, P. A.; Najimi, M.; Sokal, E. M. Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells. Gastroenterology 134(3):833–848; 2008
3. Cavazzana-Calvo, M.; Payen, E.; Negre, O.; Wang, G.; Hehir, K.; Fusil, F.; Down, J.; Denaro, M.; Brady, T.; Westerman, K.; Cavallesco, R.; Gillet-Legrand, B.; Caccavelli, L.; Sgarra, R.; Maouche-Chretien, L.; Bernaudin, F.; Girot, R.; Dorazio, R.; Mulder, G. J.; Polack, A.; Bank, A.; Soulier, J.; Larghero, J.; Kabbara, N.; Dalle, B.; Gourmel, B.; Socie, G.; Chretien, S.; Cartier, N.; Aubourg, P.; Fischer, A.; Cornetta, K.; Galacteros, F.; Beuzard, Y.; Gluckman, E.; Bushman, F.; Hacein-Bey-Abina, S.; Leboulch, P. Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia. Nature 467(7313): 318–322; 2010
4. Chang, C. J.; Yen, M. L.; Chen, Y. C.; Chien, C. C.; Huang, H. I.; Bai, C. H.; Yen, B. L. Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma. Stem Cells 24(11):2466–2477; 2006
5. Chao, K. C.; Yang, H. T.; Chen, M. W. Human umbilical cord mesenchymal stem cells suppress breast cancer tumourigenesis through direct cell-cell contact and internalization. J. Cell. Mol. Med. 16(8):1803–1815; 2012
6. Chatzistamatiou, T. K.; Papassavas, A. C.; Michalopoulos, E.; Gamaloutsos, C.; Mallis, P.; Gontika, I.; Panagouli, E.; Koussoulakos, S. L.; Stavropoulos-Giokas, C. Optimizing isolation culture and freezing methods to preserve Wharton’s jelly’s mesenchymal stem cell (MSC) properties: An MSC banking protocol validation for the Hellenic Cord Blood Bank. Transfusion 54(12):3108–3120; 2014
7. Cho, M.; Lee, E. J.; Nam, H.; Yang, J. H.; Cho, J.; Lim, J. M.; Lee, G. Human feeder layer system derived from umbilical cord stromal cells for human embryonic stem cells. Fertil. Steril. 93(8):2525–2531; 2010
8. De Miguel, M. P.; Fuentes-Julian, S.; Blazquez-Martinez, A.; Pascual, C. Y.; Aller, M. A.; Arias, J.; Arnalich-Montiel, F. Immuno-suppressive properties of mesenchymal stem cells: Advances and applications. Curr. Mol. Med. 12(5):574–591; 2012
9. Ding, D. C.; Shyu, W. C.; Chiang, M. F.; Lin, S. Z.; Chang, Y. C.; Wang, H. J.; Su, C. Y.; Li, H. Enhancement of neuroplasticity through up-regulation of beta1-integrin in human umbilical cord-derived stromal cell implanted stroke model. Neurobiol. Dis. 27(3):339–353; 2007
10. Ding, D. C.; Shyu, W. C.; Lin, S. Z. Mesenchymal stem cells. Cell Transplant. 20(1):5–14; 2011
11. Ding, D. C.; Shyu, W. C.; Lin, S. Z.; Li, H. Current concepts in adult stem cell therapy for stroke. Curr. Med. Chem. 13(29):3565–3574; 2006
12. Ding, D. C.; Shyu, W. C.; Lin, S. Z.; Liu, H. W.; Chiou, S. H.; Chu, T. Y. Human umbilical cord mesenchymal stem cells support non-tumorigenic expansion of human embryonic stem cells. Cell Transplant. 21(7):1515–1527; 2012
13. Ding, D. C.; Wu, K. C.; Chou, H. L.; Hung, W. T.; Liu, H. W.; Chu, T. Y. Human infra-patellar fat pad-derived stromal cells have more potent differentiation capacity than other mesenchymal cells and can be enhanced by hyaluronan. Cell Transplant. 2014
14. Dominici, M.; Le Blanc, K.; Mueller, I.; Slaper-Cortenbach, I.; Marini, F.; Krause, D.; Deans, R.; Keating, A.; Prockop, D.; Horwitz, E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4): 315–317; 2006
15. El Omar, R.; Beroud, J.; Stoltz, J. F.; Menu, P.; Velot, E.; Decot, V. Umbilical cord mesenchymal stem cells: The new gold standard for mesenchymal stem cell-based therapies? Tissue Eng. Part B Rev. 20(5):523–544; 2014
16. English, K.; French, A.; Wood, K. J. Mesenchymal stromal cells: Facilitators of successful transplantation? Cell Stem Cell 7(4):431–442; 2010
17. Fan, C. G.; Zhang, Q. J.; Zhou, J. R. Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord. Stem Cell Rev. 7(1):195–207; 2011
18. Fong, C. Y.; Gauthaman, K.; Cheyyatraivendran, S.; Lin, H. D.; Biswas, A.; Bongso, A. Human umbilical cord Wharton’s jelly stem cells and its conditioned medium support hematopoietic stem cell expansion ex vivo. J. Cell. Biochem. 113(2):658–668; 2012
19. Fong, C. Y.; Richards, M.; Manasi, N.; Biswas, A.; Bongso, A. Comparative growth behaviour and characterization of stem cells from human Wharton’s jelly. Reprod. Biomed. Online 15(6):708–718; 2007
20. Fong, C. Y.; Subramanian, A.; Biswas, A.; Gauthaman, K.; Srikanth, P.; Hande, M. P.; Bongso, A. Derivation efficiency, cell proliferation, freeze-thaw survival, stem-cell properties and differentiation of human Wharton’s jelly stem cells. Reprod. Biomed. Online 21(3):391–401; 2010
21. Fu, Y. S.; Shih, Y. T.; Cheng, Y. C.; Min, M. Y. Transformation of human umbilical mesenchymal cells into neurons in vitro. J. Biomed. Sci. 11(5):652–660; 2004
22. Ganta, C.; Chiyo, D.; Ayuzawa, R.; Rachakatla, R.; Pyle, M.; Andrews, G.; Weiss, M.; Tamura, M.; Troyer, D. Rat umbilical cord stem cells completely abolish rat mammary carcinomas with no evidence of metastasis or recurrence 100 days post-tumor cell inoculation. Cancer Res. 69(5): 1815–1820; 2009
23. Gauthaman, K.; Yee, F. C.; Cheyyatraivendran, S.; Biswas, A.; Choolani, M.; Bongso, A. Human umbilical cord Wharton’s jelly stem cell (hWJSC) extracts inhibit cancer cell growth in vitro. J. Cell. Biochem. 113(6):2027–2039; 2012
24. Gong, W.; Han, Z.; Zhao, H.; Wang, Y.; Wang, J.; Zhong, J.; Wang, B.; Wang, S.; Wang, Y.; Sun, L.; Han, Z. Banking human umbilical cord-derived mesenchymal stromal cells for clinical use. Cell Transplant. 21(1):207–216; 2012
25. Gonzalez, R.; Griparic, L.; Umana, M.; Burgee, K.; Vargas, V.; Nasrallah, R.; Silva, F.; Patel, A. An efficient approach to isolation and characterization of pre- and post-natal umbilical cord lining stem cells for clinical applications. Cell Transplant. 19(11):1439–1449; 2010
26. Gore, A.; Li, Z.; Fung, H. L.; Young, J. E.; Agarwal, S.; Antosiewicz-Bourget, J.; Canto, I.; Giorgetti, A.; Israel, M. A.; Kiskinis, E.; Lee, J. H.; Loh, Y. H.; Manos, P. D.; Montserrat, N.; Panopoulos, A. D.; Ruiz, S.; Wilbert, M. L.; Yu, J.; Kirkness, E. F.; Izpisua Belmonte, J. C.; Rossi, D. J.; Thomson, J. A.; Eggan, K.; Daley, G. Q.; Goldstein, L. S.; Zhang, K. Somatic coding mutations in human induced pluripotent stem cells. Nature 471(7336):63–67; 2011
27. Greco, S. J.; Liu, K.; Rameshwar, P. Functional similarities among genes regulated by OCT4 in human mesenchymal and embryonic stem cells. Stem Cells 25(12):3143–3154; 2007
28. Hacein-Bey-Abina, S.; Von Kalle, C.; Schmidt, M.; McCormack, M. P.; Wulffraat, N.; Leboulch, P.; Lim, A.; Osborne, C. S.; Pawliuk, R.; Morillon, E.; Sorensen, R.; Forster, A.; Fraser, P.; Cohen, J. I.; de Saint Basile, G.; Alexander, I.; Wintergerst, U.; Frebourg, T.; Aurias, A.; Stoppa-Lyonnet, D.; Romana, S.; Radford-Weiss, I.; Gross, F.; Valensi, F.; Delabesse, E.; Macintyre, E.; Sigaux, F.; Soulier, J.; Leiva, L. E.; Wissler, M.; Prinz, C.; Rabbitts, T. H.; Le Deist, F.; Fischer, A.; Cavazzana-Calvo, M. LMO2- associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302(5644):415–419; 2003
29. He, H.; Nagamura-Inoue, T.; Tsunoda, H.; Yuzawa, M.; Yamamoto, Y.; Yorozu, P.; Agata, H.; Tojo, A. Stage-specific embryonic antigen 4 in Wharton’s jelly-derived mesenchymal stem cells is not a marker for proliferation and multipotency. Tissue Eng. Part A 20(7–8):1314–1324; 2014
30. Hsieh, J. Y.; Fu, Y. S.; Chang, S. J.; Tsuang, Y. H.; Wang, H. W. Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton’s jelly of umbilical cord. Stem Cells Dev. 19(12):1895–1910; 2010
31. Ishige, I.; Nagamura-Inoue, T.; Honda, M. J.; Harnprasopwat, R.; Kido, M.; Sugimoto, M.; Nakauchi, H.; Tojo, A. Comparison of mesenchymal stem cells derived from arterial, venous, and Wharton’s jelly explants of human umbilical cord. Int. J. Hematol. 90(2):261–269; 2009
32. Kim, S. S.; Kwon, D. W.; Im, I.; Kim, Y. D.; Hwang, D. S.; Holliday, L. S.; Donatelli, R. E.; Son, W. S.; Jun, E. S. Differentiation and characteristics of undifferentiated mesenchymal stem cells originating from adult premolar periodontal ligaments. Korean J. Orthod. 42(6):307–317; 2012
33. Kita, K.; Gauglitz, G. G.; Phan, T. T.; Herndon, D. N.; Jeschke, M. G. Isolation and characterization of mesenchymal stem cells from the sub-amniotic human umbilical cord lining membrane. Stem Cells Dev. 19(4):491–502; 2010
34. La Rocca, G.; Anzalone, R.; Corrao, S.; Magno, F.; Loria, T.; Lo Iacono, M.; Di Stefano, A.; Giannuzzi, P.; Marasa, L.; Cappello, F.; Zummo, G.; Farina, F. Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: Differentiation potential and detection of new markers. Histochem. Cell Biol. 131(2): 267–282; 2009
35. La Rocca, G.; Corrao, S.; Lo Iacono, M.; Corsello, T.; Farina, F.; Anzalone, R. Novel immuno-modulatory markers expressed by human WJ-MSC: An update review in regenerative and reparative medicine. Open Tissue Eng. Reg. Med. J. 5:50–58; 2012
36. Lai, D.; Cheng, W.; Liu, T.; Jiang, L.; Liu, T.; Huang, Q.; Guo, L. Optimization of culture conditions to support undifferentiated growth of human embryonic stem cells. Cell. Reprogram. 12(3):305–314; 2010
37. Lee, J. M.; Jung, J.; Lee, H. J.; Jeong, S. J.; Cho, K. J.; Hwang, S. G.; Kim, G. J. Comparison of immuno-modulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells. Int. Immunopharmacol. 13(2):219–224; 2012
38. Lim, I. J.; Phan, T. T. Epithelial and mesenchymal stem cells from the umbilical cord lining membrane. Cell Transplant. 23(4–5):497–503; 2014
39. Lin, H. D.; Fong, C. Y.; Biswas, A.; Choolani, M.; Bongso, A. Human Wharton’s jelly stem cells, its conditioned medium and cell-free lysate inhibit the growth of human lymphoma cells. Stem Cell Rev. 10(4):573–586; 2014
40. Lin, S. Z.; Chang, Y. J.; Liu, J. W.; Chang, L. F.; Sun, L. Y.; Li, Y. S.; Luo, G. H.; Liao, C. H.; Chen, P. H.; Chen, T. M.; Lee, R. P.; Yang, K. L.; Harn, H. J.; Chiou, T. W. Transplantation of human Wharton’s Jelly-derived stem cells alleviates chemically induced liver fibrosis in rats. Cell Transplant. 19(11):1451–1463; 2010
41. Liu, S. P.; Ding, D. C.; Wang, H. J.; Su, C. Y.; Lin, S. Z.; Li, H.; Shyu, W. C. Non-senescent Hsp27-upregulated MSCs implantation promotes neuroplasticity in stroke model. Cell Transplant. 19(10):1261–1279; 2010
42. Ma, L.; Feng, X. Y.; Cui, B. L.; Law, F.; Jiang, X. W.; Yang, L. Y.; Xie, Q. D.; Huang, T. H. Human umbilical cord Wharton’s Jelly-derived mesenchymal stem cells differentiation into nerve-like cells. Chin. Med. J. 118(23): 1987–1993; 2005
43. Ma, Y.; Hao, X.; Zhang, S.; Zhang, J. The in vitro and in vivo effects of human umbilical cord mesenchymal stem cells on the growth of breast cancer cells. Breast Cancer Res. Treat. 133(2):473–485; 2012
44. Manochantr, S.; U-pratya, Y.; Kheolamai, P.; Rojphisan, S.; Chayosumrit, M.; Tantrawatpan, C.; Supokawej, A.; Issaragrisil, S. Immunosuppressive properties of mesenchymal stromal cells derived from amnion, placenta, Wharton’s jelly and umbilical cord. Intern. Med. J. 43(4):430–439; 2013
45. Martin, A.; Badell, M. Umbilical cord blood banking. Postgrad. Obstet. Gynecol. 34(15):1–6; 2014
46. Martin, M. J.; Muotri, A.; Gage, F.; Varki, A. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat. Med. 11(2):228–232; 2005
47. Maurya, D. K.; Doi, C.; Kawabata, A.; Pyle, M. M.; King, C.; Wu, Z.; Troyer, D.; Tamura, M. Therapy with un-engineered naive rat umbilical cord matrix stem cells markedly inhibits growth of murine lung adenocarcinoma. BMC Cancer 10: 590; 2010
48. Mennan, C.; Wright, K.; Bhattacharjee, A.; Balain, B.; Richardson, J.; Roberts, S. Isolation and characterisation of mesenchymal stem cells from different regions of the human umbilical cord. Biomed. Res. Int. 2013:916136; 2013
49. Mitchell, K. E.; Weiss, M. L.; Mitchell, B. M.; Martin, P.; Davis, D.; Morales, L.; Helwig, B.; Beerenstrauch, M.; Abou- Easa, K.; Hildreth, T.; Troyer, D.; Medicetty, S. Matrix cells from Wharton’s jelly form neurons and glia. Stem Cells 21(1):50–60; 2003
50. Nagamura-Inoue, T.; He, H. Umbilical cord-derived mesenchymal stem cells: Their advantages and potential clinical utility. World J. Stem Cells 6(2):195–202; 2014
51. Okita, K.; Ichisaka, T.; Yamanaka, S. Generation of germline-competent induced pluripotent stem cells. Nature 448(7151):313–317; 2007
52. Parekkadan, B.; Milwid, J. M. Mesenchymal stem cells as therapeutics. Annu. Rev. Biomed. Eng. 12:87–117; 2010
53. Pittenger, M. F.; Mackay, A. M.; Beck, S. C.; Jaiswal, R. K.; Douglas, R.; Mosca, J. D.; Moorman, M. A.; Simonetti, D. W.; Craig, S.; Marshak, D. R. Multilineage potential of adult human mesenchymal stem cells. Science 284(5411): 143–147; 1999
54. Prasanna, S. J.; Jahnavi, V. S. Wharton’s jelly mesenchymal stem cells as off-the-shelf cellular therapeutics: A closer look into their regenerative and immuno-modulatory properties. Open Tissue Eng. Reg. Med. J. 4:28–38; 2011
55. Rachakatla, R. S.; Marini, F.; Weiss, M. L.; Tamura, M.; Troyer, D. Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors. Cancer Gene Ther. 14(10):828–835; 2007
56. Reza, H. M.; Ng, B. Y.; Gimeno, F. L.; Phan, T. T.; Ang, L. P. Umbilical cord lining stem cells as a novel and promising source for ocular surface regeneration. Stem Cell Rev. 7(4):935–947; 2011
57. Reza, H. M.; Ng, B. Y.; Phan, T. T.; Tan, D. T.; Beuerman, R. W.; Ang, L. P. Characterization of a novel umbilical cord lining cell with CD227 positivity and unique pattern of P63 expression and function. Stem Cell Rev. 7(3):624–638; 2011
58. Saben, J.; Thakali, K. M.; Lindsey, F. E.; Zhong, Y.; Badger, T. M.; Andres, A.; Shankar, K. Distinct adipogenic differentiation phenotypes of human umbilical cord mesenchymal cells dependent on adipogenic conditions. Exp. Biol. Med. 239(10):1340–1351; 2014
59. Salehinejad, P.; Alitheen, N. B.; Ali, A. M.; Omar, A. R.; Mohit, M.; Janzamin, E.; Samani, F. S.; Torshizi, Z.; Nematollahi-Mahani, S. N. Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton’s jelly. In Vitro Cell Dev. Biol. Anim. 48(2):75–83; 2012
60. Selmani, Z.; Naji, A.; Gaiffe, E.; Obert, L.; Tiberghien, P.; Rouas-Freiss, N.; Carosella, E. D.; Deschaseaux, F. HLA-G is a crucial immunosuppressive molecule secreted by adult human mesenchymal stem cells. Transplantation 87(9 Suppl):S62–66; 2009
61. Selmani, Z.; Naji, A.; Zidi, I.; Favier, B.; Gaiffe, E.; Obert, L.; Borg, C.; Saas, P.; Tiberghien, P.; Rouas-Freiss, N.; Carosella, E. D.; Deschaseaux, F. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. Stem Cells 26(1):212–222; 2008
62. Seo, K. W.; Lee, S. R.; Bhandari, D. R.; Roh, K. H.; Park, S. B.; So, A. Y.; Jung, J. W.; Seo, M. S.; Kang, S. K.; Lee, Y. S.; Kang, K. S. OCT4A contributes to the stemness and multi-potency of human umbilical cord blood-derived multipotent stem cells (hUCB-MSCs). Biochem. Biophys. Res. Commun. 384(1):120–125; 2009
63. Sinha, M.; Jang, Y. C.; Oh, J.; Khong, D.; Wu, E. Y.; Manohar, R.; Miller, C.; Regalado, S. G.; Loffredo, F. S.; Pancoast, J. R.; Hirshman, M. F.; Lebowitz, J.; Shadrach, J. L.; Cerletti, M.; Kim, M. J.; Serwold, T.; Goodyear, L. J.; Rosner, B.; Lee, R. T.; Wagers, A. J. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science 344(6184):649–652; 2014
64. Sun, B.; Yu, K. R.; Bhandari, D. R.; Jung, J. W.; Kang, S. K.; Kang, K. S. Human umbilical cord blood mesenchymal stem cell-derived extracellular matrix prohibits metastatic cancer cell MDA-MB-231 proliferation. Cancer Lett. 296(2): 178–185; 2010
65. Tsagias, N.; Koliakos, I.; Karagiannis, V.; Eleftheriadou, M.; Koliakos, G. G. Isolation of mesenchymal stem cells using the total length of umbilical cord for transplantation purposes. Transfus. Med. 21(4):253–261; 2011
66. Tsai, M. S.; Lee, J. L.; Chang, Y. J.; Hwang, S. M. Isolation of human multi-potent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum. Reprod. 19(6):1450–1456; 2004
67. Tsai, P. C.; Fu, T. W.; Chen, Y. M.; Ko, T. L.; Chen, T. H.; Shih, Y. H.; Hung, S. C.; Fu, Y. S. The therapeutic potential of human umbilical mesenchymal stem cells from Wharton’s jelly in the treatment of rat liver fibrosis. Liver Transpl. 15(5):484–495; 2009
68. Tsai, P. J.; Wang, H. S.; Shyr, Y. M.; Weng, Z. C.; Tai, L. C.; Shyu, J. F.; Chen, T. H. Transplantation of insulinproducing cells from umbilical cord mesenchymal stem cells for the treatment of streptozotocin-induced diabetic rats. J. Biomed. Sci. 19:47; 2012
69. Uccelli, A.; Moretta, L.; Pistoia, V. Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 8(9):726–736; 2008
70. Villeda, S. A.; Plambeck, K. E.; Middeldorp, J.; Castellano, J. M.; Mosher, K. I.; Luo, J.; Smith, L. K.; Bieri, G.; Lin, K.; Berdnik, D.; Wabl, R.; Udeochu, J.; Wheatley, E. G.; Zou, B.; Simmons, D. A.; Xie, X. S.; Longo, F. M.; Wyss-Coray, T. Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice. Nat. Med. 20(6):659–663; 2014
71. Wang, H. S.; Hung, S. C.; Peng, S. T.; Huang, C. C.; Wei, H. M.; Guo, Y. J.; Fu, Y. S.; Lai, M. C.; Chen, C. C. Mesenchymal stem cells in the Wharton’s jelly of the human umbilical cord. Stem Cells 22(7):1330–1337; 2004
72. Wang, H. S.; Shyu, J. F.; Shen, W. S.; Hsu, H. C.; Chi, T. C.; Chen, C. P.; Huang, S. W.; Shyr, Y. M.; Tang, K. T.; Chen, T. H. Transplantation of insulin-producing cells derived from umbilical cord stromal mesenchymal stem cells to treat NOD mice. Cell Transplant. 20(3):455–466; 2011
73. Wang, Y.; Han, Z. B.; Ma, J.; Zuo, C.; Geng, J.; Gong, W.; Sun, Y.; Li, H.; Wang, B.; Zhang, L.; He, Y.; Han, Z. C. A toxicity study of multiple-administration human umbilical cord mesenchymal stem cells in cynomolgus monkeys. Stem Cells Dev. 21(9):1401–1408; 2012
74. Weiss, M. L.; Anderson, C.; Medicetty, S.; Seshareddy, K. B.; Weiss, R. J.; VanderWerff, I.; Troyer, D.; McIntosh, K. R. Immune properties of human umbilical cord Wharton’s jelly-derived cells. Stem Cells 26(11):2865–2874; 2008
75. William, P. L.; Banister, L. H. Gray’s anatomy. London, UK: Churchill Livingstone; 1995
76. Yamanaka, S.; Takahashi, K. [Induction of pluripotent stem cells from mouse fibroblast cultures]. Tanpakushitsu Kakusan Koso 51(15):2346–2351; 2006
77. Yu, S.; Long, J.; Yu, J.; Du, J.; Ma, P.; Ma, Y.; Yang, D.; Fan, Z. Analysis of differentiation potentials and gene expression profiles of mesenchymal stem cells derived from periodontal ligament and Wharton’s jelly of the umbilical cord. Cells Tissues Organs 197(3):209–223; 2013.